A Phase 2 Multi-center, Double-blinded, Placebo-controll

Project: Research project

Project Details

Description

A Phase 2 Multi-center, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of VX809 Alone and In Combination With VX 770.
StatusFinished
Effective start/end date11/4/109/11/15

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.